Using Thymoquinone As a Novel Drug Targeting EF2K Activity in Treating Pancreatic Cancer

Authors

Chelsea O. Popoola, University of Notre DameFollow
Bulent Ozpolat, The University of Texas MD Anderson Cancer Center
Pinar Atalay, The University of Texas MD Anderson Cancer Center
Rumeysa Ozyurt, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Thymoquinone, EF2K, Pancreatic Cancer, p-EF2

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

University Outreach - University of Notre Dame

Recommended Citation

Popoola, Chelsea O.; Ozpolat, Bulent; Atalay, Pinar; and Ozyurt, Rumeysa, "Using Thymoquinone As a Novel Drug Targeting EF2K Activity in Treating Pancreatic Cancer" (2021). Summer Experience 2021. 107.
https://openworks.mdanderson.org/sumexp21/107